Why Expertise Matters in Target Expression and Assay Development for Cancer Clinical Trials

Why Expertise Matters in Target Expression and Assay Development for Cancer Clinical Trials

Make better clinical trial decisions by working with a biomarker expert to adopt clinical trial ready IHC assays early in the drug development process
Read More
Advancing Cell Therapy Success in Solid Tumors

Advancing Cell Therapy Success in Solid Tumors

CAR-T cell therapy has proven highly successful in treating hematological cancers and the race is on to extend cellular therapies to a wider range of cancers.
Read More
SpecimenSeq Cancer Tissue Samples with Known Mutations

SpecimenSeq Cancer Tissue Samples with Known Mutations

Thousands of tissue samples with full genotyping data make cohort selection a breeze. SpecimenSeq: Saving time, reducing cost, and accelerating research
Read More
Visualizing Patterns and Trends Across Cancer Types Using DTCs

Visualizing Patterns and Trends Across Cancer Types Using DTCs

Analyzing thousands of cancer tissue samples in the form of DTCs provides insights into the nature of different cancer indications
Read More
Getting The Most from Dissociated Tissue & Tumor Cells

Getting The Most from Dissociated Tissue & Tumor Cells

Best practices in the processing and analysis of dissociated tissue cell samples deliver insights into disease and reveal new therapeutic targets
Read More
Dissociated Tumor Cells: The Key to Next-Generation Therapy

Dissociated Tumor Cells: The Key to Next-Generation Therapy

Dissociated tissue cell (DTC) samples maximize value and usability of fresh tissues to rapidly advance oncology research at any scale
Read More
5 Questions to Ask Your FFPE Provider (and What Their Answers Should Be)

5 Questions to Ask Your FFPE Provider (and What Their Answers Should Be)

FFPE tissue samples are critical for research, but are you getting what you think? A few simple questions can help validate your supplier and give confidence in your samples.
Read More
Optimizing Viability for Cryopreserved Leukopaks

Optimizing Viability for Cryopreserved Leukopaks

Setting up for success: How proper handling and processing pre-freeze can ensure the maximum levels of cell viability after cryopreservation.
Read More
Cryopreserved Leukopaks: Addressing the Viability Myth

Cryopreserved Leukopaks: Addressing the Viability Myth

Recent publications, including a landmark paper from Novartis¹, demonstrate the viability and utility of cryopreserved leukopaks, dispelling the viability myth.
Read More
Addressing the Achilles Heel of T-Cell Therapy

Addressing the Achilles Heel of T-Cell Therapy

Cryopreserved leukopaks eliminate the constraints imposed by a reliance on fresh human cells for T-cell therapies. Has the tide turned in favor of frozen cells?
Read More

To propel your projects with The Power of Discovery.™

Contact Us Today

Let us know about your project!

Image